The goal of blood pressure control for prevention of early diabetic microvascular complications

Related Experiment Video

Updated: Jun 2, 2026

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice
04:36

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice

Published on: January 12, 2024

Mark E Williams1

  • 1Renal Unit, Joslin Diabetes Center, 1 Joslin Place, Boston, MA 02215, USA. mark.williams@joslin.harvard.edu

Current Diabetes Reports
|April 29, 2011
PubMed

Insights

Lowering blood pressure offers benefits for diabetic microvascular complications, similar to glycemic control. Primary prevention through blood pressure reduction is most effective for patients with hypertension, cardiovascular risks, or advanced age.

Area of Science:

  • Nephrology
  • Endocrinology
  • Cardiology

Background:

  • Hypertension is a significant risk factor for diabetic retinopathy and kidney disease.
  • Hypertension prevalence increases with kidney disease progression, often coexisting with diabetes.
  • Microalbuminuria significantly elevates risks for nephropathy and cardiovascular complications.

Purpose of the Study:

  • To review the relationship between hypertension, diabetes, and kidney disease.
  • To explore the rationale and evidence for primary prevention of microvascular complications.
  • To assess the benefits of blood pressure reduction in select patient groups.

Main Methods:

  • Review of available data on hypertension management in diabetic patients.
  • Analysis of studies investigating renin-angiotensin blockade for primary prevention.
  • Evaluation of evidence supporting blood pressure reduction for microvascular complications.

Main Results:

  • Blood pressure reduction may benefit diabetic microvascular complications, comparable to glycemic control.
  • Primary prevention via blood pressure reduction is most beneficial for individuals with hypertension, cardiovascular risks, or elderly patients.
  • Renin-angiotensin blockade is a key strategy in the primary prevention of microalbuminuria.

Conclusions:

  • Lowering blood pressure is a crucial strategy for managing diabetic microvascular complications.
  • Primary prevention of microvascular complications through blood pressure control is recommended for high-risk diabetic patients.
  • Further research supports blood pressure management as a cornerstone in preventing diabetic kidney disease and retinopathy.

More Related Videos

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...